Hans Lennart Rudolf Wigzell - 04 Aug 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Hans Wigzell
Issuer symbol
SRPT
Transactions as of
04 Aug 2023
Net transactions value
-$1,165,350
Form type
4
Filing time
08 Aug 2023, 20:00:06 UTC
Previous filing
08 Mar 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $435,450 +15,000 +71% $29.03 35,994 04 Aug 2023 Direct
transaction SRPT Common Stock Sale $1,600,800 -15,000 -42% $106.72 20,994 04 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 04 Aug 2023 Common Stock 15,000 $29.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.42 to $107.04 per share. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.